Guideline for polymorphic light eruption;Polymorphe lichtdermatose

JDDG - Journal of the German Society of Dermatology

Volumn 2, Issue 3, 2004, Pages 220-226

  Neumann, Norbert J ^a   Hölzle, Erhard ^a,b   Lehmann, Percy ^a  

^a Subkommn Phys Therap in Dermatol   (Germany)

^b KLINIKUM OLDENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CALCIUM; CORTICOSTEROID; HYDROXYCHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; METHOXSALEN; NICOTINAMIDE; TRANSCRIPTION FACTOR AP 2;

ACTINIC KERATOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ERYTHEMA; HISTOPATHOLOGY; HUMAN; LUPUS ERYTHEMATOSUS; LYMPHOCYTIC INFILTRATION; PATHOGENESIS; PHOTOCHEMOTHERAPY; PHOTODERMATOSIS; PHOTOTHERAPY; PRACTICE GUIDELINE; SHORT SURVEY; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA;

EID: 1642325766     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2004.03052.x     Document Type: Short Survey

References (43)

1. Berg M, Ros AM, Berne B (1994) Ultraviolet A phototherapy and trimethylpsoralen UVA photochemotherapy in polymorphous light eruption - a controlled study. Photodermatology, Photoimmunology and Photomedicine 10:139-143.
2. Berg, M (1989) Epidemiological studies of the influence of sunlight on the skin. Photodermatol 6: 80-84.
3. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson J (1993) A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 129: 708-12.
4. Corbett, MF, Hawk JL, Herxheimer A, Magnus IA (1982) Controlled therapeutic trials in polymorphous light eruption. Br J Dermatol 107: 571-581.
5. Diepgen TI, Häberle M, Fartasch M, Stüben O, Hornstein OP (1989) Charakteristika der polymorphen Lichtdermatose - Ergebnisse einer prospektiven Befragung und Untersuchung 302 Betroffener. Z Hautkr 64: 279-285.
6. Eberlein-Konig B, Fesq H, Abeck D, Przybilla B, Placzek M, Ring J (2000) Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol Photoimmunol Photomed 16: 50-2.
7. Fitzpatrick JE, Thompson PB, Aeling JL, Huff C (1983) Photosensitive recurrent recema multiforme. J Am Acad Dermatol 9: 419-423.
8. Grether-Beck S, Budde MA, Schmidt-Brenden H, Krutmann J (2000) Lack of AP2B expression in lesional skin of patients with polymorphous light eruption. Allergo J 9: 42.
9. Grether-Beck S, Schmitt H, Grewe M, Buettner R, Krutmann J (1997) The balance between expression of transcription factor AP2 and its alternative splice product AP28 controls ultraviolet A radiation (UVAR)-induced ICAM-1 expression in human cells. J Invest Dermatol 109: 422.
10. Häberle MM, Arnold HU, Koch E, Grühn OP, Hornstein (1991) Nikotinsäureamid zur Prophylaxe der polymorphen Lichtdermatose (PLD) - eine plazebokontrollierte Doppelblindstudie. Vita Min Spur 6: 29-37.
11. Hadshiew I, Stäb F, Untiedt S, Bohnsack K, Rippke F, Hölzle E (1997) Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption (PLE). Dermatology 195.362-368.
12. Hölzle E (2003) Polymorphe Lichtdermatose. In: Photodermatosen und Lichtreaktionen der Haut. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 153-182.
13. Hölzle E, G. Plewig G, Hofmann C, Roser-Maass E (1982) Polymorphous light eruption. Experimental reproduction of skin lesions. J Am Acad Dermatol 7: 111-125.
14. Hönigsmann H (1989) Wirkung einer therapeutischen Lichtschutzcreme auf die Phototestreaktion bei polymorpher Lichtdermatose. Z Hautkr 64: 1065-1068.
15. Hönigsmann H, Ortel B (1988) Die polymorphe Lichtdermatose - Photobiologische Diagnostik und Therapie. Z Hautkr 63: 676-678,.
16. Hood AF, Elpern DJ, Morison EL (1986) Histopathologic findings in papulovesicular light eruption. J Cut Pathol 13: 13-21.
17. Ippen H (1980) Photodermatitis multiformis acuta. Dermatologische Monatsschrift 166: 145-150.
18. Jansén CT (1979) Erythemal and pigmentary phototest reactions in polymorphous light eruption. Acta Derm Venereol (Stockh.) 59: 499-503.
19. Jansén CT (1979) The natural history of polymorphous light eruptions. Arch Dermatol 115: 165-169.
20. Jansén CT (1985) Oral carotenoid treatment in polymorphous light eruption. A cross-over comparison with oxychloroquine and placebo. Photodermatol 2: 166-169.
21. Jeanmougin M, Civatte J (1987) Benign summer light eruption: the most common photodermatosis. J Am Acad Dermatol 17: 690-691.
22. Kerscher M, Przybilla B, Rueff F (1998) Successful preventive treatment of polymorphous light eruption with an E. coli-filtrate. Allergo J 7: 261-263.
23. Krutmann J, Grewe M (1995) Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 105: 67S-70S.
24. Lane PR, Hogan DJ, Martel MJ, Reeder B, Irving J (1992) Actinic prurigo: Clinical features and prognosis. J Am Acad Dermatol 26: 683-692.
25. Lehman p, Hölzle E, Kind P et al. (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22: 181-187.
26. Lindmaier A, Neumann R (1991) Der PLD-Patient. Hautarzt 42: 430-433.
27. McFadden N (1984) UVA sensitivity and topical photoprotection in polymorphous light eruption. Photodermatol 1: 76-78.
28. Menagé P du H, Norris P, Cheong W, Hawk J (1992) Short course PUVA therapy is effective in polymorphic light eruption. Br J of Dermatol 127: 32.
29. Milde P, Hölzle E, Neumann N, Lehmann P, Trautvetter U, Plewig G (1991) Chronische aktinische Dermatitis. Konzeption u Fallbeispiele. Hautarzt 42: 617-622.
30. Molin L, Volden G (1987) Treatment of polymorphous light eruption with PUVA and prednisolone. Photodermatol 4: 107-108.
31. Murphy GM, Hawk JL, Magnus IA (1987) Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 116: 379-386.
32. Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JLM, Magnus IA (1987) Prophylactic PUVA and UVB therapy in polymorphic light eruption: a controlled trial. Br J Dermatol 116: 531-8.
33. Norris DA (1993) Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 100: 58s-68s.
34. Norris PG, Hawk JLM (1989) Succesful treatment of severe plymorphous light eruption with azathioprine. Arch Dermatol 125: 1377-1379.
35. Norris PG, Morris J, McGibbon DM, Chu AC, Hawk JLM (1989) Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol 120: 173-180.
36. Orr PH, Birt AR (1984) Hereditary polymorphous light eruption in Canadian Inuit. Int J. Dermatol 23: 472-475.
37. Ortel B, Tanew A, Hönigsmann H, Wolff K (1986) Polymorphous light eruption. Action spectrum and photoprotection. J Am Acad Dermatol 14: 748-753.
38. Proby C, Baker C, Morton O, Hawk J (1993) New broad-spectrum sunscreen for polymorphic light eruption. Lancet 341: 1347-8.
39. Przybilla B, Heppeler M, Ruzicka T (1989) Preventive effect of an E. coli-filtrate (Colibiogen) in polymorphous light eruption. Br J Dermatol 121: 229-233.
40. 2 levels in skin. J Invest Dermatol 105: 532-5.
41. Ros A, Wennersten G (1986) Current aspects of polymorphous light eruptions in Sweden. Photodermatol 3: 298-302.
42. Sippel A (1996) Klinisch-experimentelle Untersuchungen zur Wirksamkeit einer systemischen Medikation zur Prophylaxe der polymorphen Lichtdermatose. Deutsche Hochschulschr 2321. Hänsel-Hohenhausen Egelsbach.
43. Wurzel R (1999) Prophylaxe der polymorphen Lichtdermatose. Akt Dermatol 25: 329-333.